Edwards Lifesciences (EW), Cigna (CI), Vertex Pharmaceuticals (VRTX), Aetna (AET), Amerigroup (AGP), CenterPoint Energy (CNP) and El Paso (EP) were upgraded or downgraded by analysts.
Cigna (CI) initiated with a Neutral from Not Rated at Goldman.Target $49.
Vertex Pharmaceuticals (VRTX) downgraded to Neutral from Buy at Goldman.Goldman downgraded Vertex based on valuation. Price target remains $40.
Aetna (AET) downgraded to Buy from Conviction Buy at Goldman.Goldman removed Aetna from its Conviction Buy List citing limited upside. Price target is $54.
Amerigroup (AGP) downgraded to Neutral from Buy at Goldman.Goldman downgraded Amerigroup based on valuation. Price target is $74.
CenterPoint Energy (CNP) upgraded to Buy from Neutral at Citigroup.Citigroup upgraded CenterPoint Energy citing the recent sell-off in shares and the company's opportunities for growth. The firm raised its price target for shares to $22 from $21.
El Paso (EP) downgraded to Neutral from Buy at Citigroup.Citigroup downgraded El Paso citing valuation but raised its price target for shares to $29 from $22.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/